Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is 3.83% higher on its value in year-to-date trading and has touched a low of $14.47 and a high of $24.64 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CPRX stock was last observed hovering at around $21.89 in the last trading session, with the day’s loss setting it -0.22%.
Currently trading at $21.67, the stock is -2.57% and -2.39% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.06 million and changing -1.01% at the moment leaves the stock 8.95% off its SMA200. CPRX registered 29.84% gain for a year compared to 6-month gain of 9.78%.
The stock witnessed a -6.15% loss in the last 1 month and extending the period to 3 months gives it a -3.82%, and is 0.05% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.62% over the week and 3.41% over the month.
Catalyst Pharmaceuticals Inc (CPRX) has around 181 employees, a market worth around $2.63B and $491.73M in sales. Current P/E ratio is 16.56 and Fwd P/E is 13.17. Profit margin for the company is 33.33%. Distance from 52-week low is 49.76% and -12.05% from its 52-week high. The company has generated returns on investments over the last 12 months (22.44%).
with sales reaching $131.43M over the same period.The EPS is expected to grow by 7.85% this year, but quarterly earnings will post 12.91% year-over-year. Quarterly sales are estimated to grow 33.42% in year-over-year returns.
The shares outstanding are 120.88M, and float is at 110.42M with Short Float at 5.18%.
The top institutional shareholder in the company is BLACKROCK INC. with over 18.69 million shares valued at $289.58 million. The investor’s holdings represent 16.0051 of the CPRX Shares outstanding. As of 2024-06-30, the second largest holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 9.13 million shares valued at $141.38 million to account for 7.7232 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 8.1 million shares representing 6.9349 and valued at over $125.47 million, while STATE STREET CORP holds 5.1052 of the shares totaling 6.03 million with a market value of $93.46 million.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
Catalyst Pharmaceuticals Inc disclosed in a document filed with the SEC on Mar 03 ’25 that Elsbernd Brian (Chief Compliance/Legal Officer) sold a total of 62,975 shares of the company’s common stock. The trade occurred on Mar 03 ’25 and was made at $22.98 per share for $1.45 million. Following the transaction, the insider now directly holds 0.19 million shares of the CPRX stock.
Still, SEC filings show that on Mar 03 ’25, Del Carmen Jeffrey (Chief Commercial Officer) disposed off 30,423 shares at an average price of $22.89 for $0.7 million. The insider now directly holds 0 shares of Catalyst Pharmaceuticals Inc (CPRX).
